Abbott India Limited

Price Chart

Risk-Adjusted Performance

Abbott India Limited (ABBOTINDIA) Price Performance

Abbott India Limited (ABBOTINDIA) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR26800.00, up 0.32% from the previous close.

Over the past year, ABBOTINDIA has traded between a low of INR26290.00 and a high of INR35670.00. The stock has lost 12.4% over this period. It is currently 24.9% below its 52-week high.

Abbott India Limited has a market capitalization of $567.04B, with a price-to-earnings ratio of 37.16.

About Abbott India Limited

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.